Answers are grounded in this paper and cite their sources.
Objectives: To find evidence on the influence of hyperglycemia in the perioperative period of liver transplantation. Methods: This is a scoping review of the PubMed, VHL, and Web of Science databases. The following descriptors were used: “Liver transplantation,” “Hyperglycemia,” and “Blood Sugar Control,” with the Boolean operator “AND,” and articles of relevance to the topic were selected. Initially, 139 articles were selected, all published in the last 20 years, in Portuguese and English. After analysis, 10 articles corresponded to the proposed objective. Results: In comparing strict control and conventional glucose control in patients undergoing liver transplantation, the average intraoperative glycemia was 143.3 mg/dL in the conventional group and 130.7 mg/dL in the strict control group, which received more insulin. The intensive care unit stay was similar with a mean of 3 days, but survival improved significantly with mean intraoperative glycemia ≤ 120 mg/dL. Patients with postreperfusion syndrome required insulin infusion more often. New-onset diabetes mellitus and early bacteremia were more frequent in the postreperfusion syndrome group. AST and ALT levels were higher in hyperglycemic patients. Surgical site infection rates correlated with postoperative hyperglycemia, with 20% for glycemia < 200 mg/dL and 52% for glycemia ≥ 200 mg/dL. Patients with postoperative glucose < 200 mg/dL had a lower rejection rate than those with glucose ≥ 200 mg/dL. Patients with diabetes had higher preoperative glycemia than patients without diabetes, with a gradual reduction after liver transplantation, whereas patients without diabetes had a peak on days 2 and 3 before returning to baseline levels. High glucose levels 48–72 h post-transplant were associated with higher mortality and a worse response to insulin treatment in the first week. Conclusion: Strict glycemic control in patients undergoing liver transplantation resulted in lower intraoperative glycemia and significantly better survival for those with glycemia ≤ 120 mg/dL, as well as lower rates of infection, rejection, and mortality, especially in patients without diabetes.
No takes yet. Share an insight, caveat, or question.
Lima et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: